New Treatment for Driveline Infection Following Implantation of a Ventricular Assist Device

Akira Sezai; Satoshi Unosawa; Makoto Taoka; Shunji Osaka; Yoshiki Kitazumi; Keito Suzuki; Toshiko Nakai; Masashi Tanaka

doi:10.1532/hsf.2899

New Treatment for Driveline Infection Following Implantation of a Ventricular Assist Device

Heart Surg Forum. 2020 Mar 13;23(2):E132-E134. doi: 10.1532/hsf.2899.

Authors

Akira Sezai¹, Satoshi Unosawa¹, Makoto Taoka¹, Shunji Osaka¹, Yoshiki Kitazumi¹, Keito Suzuki¹, Toshiko Nakai¹, Masashi Tanaka¹

Affiliation

¹ The Department of Cardiovascular Surgery, the Department of Cardiology, Nihon University School of Medicine, Tokyo, Japan.

PMID: 32364899
DOI: 10.1532/hsf.2899

Abstract

In patients with an implantable ventricular assist device (VAD), driveline infection (DLI) is a challenging complication. Once DLI occurs, it may lead to pump contamination and/or septicemia, which means that early treatment is essential. We hereby report our initial experiences of a mechanically-powered portable negative pressure wound therapy system (Smart Negative Pressure: SNaPTM) to treat DLI at an outpatient clinic.

Keywords: ventricular assist device; driveline infection; methicillin-resistant Staphylococcus aureus; negative pressure wound therapy.

2020 Forum Multimedia Publishing, LLC

Publication types

Case Reports

MeSH terms

Aged
Anti-Bacterial Agents / therapeutic use*
Heart Failure / therapy*
Heart-Assist Devices / adverse effects*
Humans
Male
Negative-Pressure Wound Therapy / methods*
Prosthesis-Related Infections / etiology
Prosthesis-Related Infections / therapy*
Treatment Outcome

Substances

Anti-Bacterial Agents